Obesity drug competition fuels Novo Nordisk restructure
By Catherine Eckford (European Pharmaceutical Review)
FDA approves first-of-a-kind intravesical drug delivery system for bladder cancer
By Catherine Eckford (European Pharmaceutical Review)
Critical Medicines Act ‘must prioritise’ EU pharmaceutical manufacturing competitiveness
By Catherine Eckford (European Pharmaceutical Review)
Understanding European regulatory requirements for low-GWP propellant transition
By Catherine Eckford (European Pharmaceutical Review)
Amid FDA turmoil Sarepta’s gene therapy worries begin to ease
By Dominic Tyer (European Pharmaceutical Review)